AbbVie
ABBV
ABBV
3,061 hedge funds and large institutions have $165B invested in AbbVie in 2023 Q2 according to their latest regulatory filings, with 150 funds opening new positions, 1,131 increasing their positions, 1,428 reducing their positions, and 183 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
18% less first-time investments, than exits
New positions opened: 150 | Existing positions closed: 183
21% less repeat investments, than reductions
Existing positions increased: 1,131 | Existing positions reduced: 1,428
44% less funds holding in top 10
Funds holding in top 10: 301 → 170 (-131)
Holders
3,061
Holding in Top 10
170
Calls
$2.74B
Puts
$1.87B
Top Buyers
| 1 | +$416M | |
| 2 | +$280M | |
| 3 | +$206M | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$170M |
| 5 |
Two Sigma Investments
New York
|
+$162M |
Top Sellers
| 1 | -$594M | |
| 2 | -$427M | |
| 3 | -$373M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$330M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$268M |